Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

about

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

Item

http://www.wikidata.org/entity/Q55473120

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

@en

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

@nl

type

Item

label

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

@en

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

@nl

prefLabel

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

@en

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

@nl

P1476

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

@en

P2093

Baiyong Li

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Junjian Xiang

http://www.w3.org/2001/XMLSchema#string

Meng Xu

http://www.w3.org/2001/XMLSchema#string

Peng Zhang

http://www.w3.org/2001/XMLSchema#string

Sheng Wang

http://www.w3.org/2001/XMLSchema#string

Yiyang Qin

http://www.w3.org/2001/XMLSchema#string

Yu Xia

http://www.w3.org/2001/XMLSchema#string

Yu Zhang

http://www.w3.org/2001/XMLSchema#string

Zhongmin Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for FGF receptor dimerization and activation

Cellular signaling by fibroblast growth factor receptors

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

Broad targeting of angiogenesis for cancer prevention and therapy

Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies

Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target

Fibroblast growth factor signalling: from development to cancer

Engineering fully human monoclonal antibodies from murine variable regions.

Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.

P304

2003-2011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.24255

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29896285

http://www.w3.org/2001/XMLSchema#string

P932

5995934

http://www.w3.org/2001/XMLSchema#string